Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Prestige Consumer Healthcare sells well-known over-the-counter health and personal care brands, from eye drops to stomach remedies, to shoppers in North America and beyond.
Prestige Consumer Healthcare is a collector of familiar drugstore brands. It doesn't invent most of them; it buys names people already trust — things like Monistat for yeast infections, Clear Eyes for red eyes, Dramamine for motion sickness, and Chloraseptic for sore throats — and then milks them for steady, reliable cash. The company's real product is shelf space and brand memory: when you reach for a box out of habit, Prestige gets paid.
The business model is simple and oddly powerful. These are low-price, high-frequency items that people buy without much thought, so they don't need a huge sales pitch or a costly research lab. Prestige spends modestly on marketing to keep the names alive and leans on pharmacies, supermarkets, and big retailers to stock them. Because the brands are cheap to make and priced with healthy margins, the company turns a large share of each sale into free cash. That cash is the whole point: Prestige has spent years paying down debt from its acquisition spree and buying back its own shares, which quietly makes each remaining share worth more. There are cracks in the story. Prestige is small next to giants like Procter & Gamble and Johnson & Johnson, and store-brand copycats keep nibbling at its prices. Its portfolio is a pile of separate brands rather than one powerhouse, so growth mostly comes from squeezing more out of existing products or finding another brand to buy. When a key product loses momentum or a retailer pushes cheaper alternatives, there's no giant lab or viral hit to fall back on.
Still, the company has a clear playbook: find a trusted but neglected brand, buy it cheaply, and harvest its loyal customers. It is less a growth machine than a cash machine — a quiet operator that profits from the fact that people would rather grab the name they know than study the label.
Saved answer · last researched 15 Nov 2026